MedCity News
1 month agoOMG science
Amgen Drug for Aggressive Type of Lung Cancer Wins Accelerated FDA Approval - MedCity News
FDA approved a new Amgen drug, Imdelltra, for second-line treatment of small cell lung cancer, offering patients another option. [ more ]